* ALZA Corp., of Palo Alto, Calif., appointed William Brody andDenise O'Leary to its board. Brody is president-designate of JohnsHopkins University. O'Leary is a general partner with MenloVentures.

British Biotech plc, of Oxford, England, appointed Pam Kirby as anexecutive director of the company in the new post of director ofinternational operations.

* Coulter Pharmaceutical Inc., of Palo Alto, Calif., named WilliamHarris as vice president and chief financial officer.

* GenVec, of Rockville, Md., promoted Thomas Smart to vicepresident, corporate development, a new position.

* Inflazyme Pharmaceuticals Inc., of Vancouver, British Columbia,appointed Ian Keith Anderson to its board. He has been presidentand/or managing director of several biotechnology companies.

* INSMED Pharmaceuticals Inc., of Richmond, Va., appointedArnold Beckett to its scientific advisory board. He co-foundedBiovail SA.

* Kosan Biosciences Inc., of Burlingame, Calif., named Philip Barrvice president of research, and appointed Francois L'Eplattenier tothe board of directors. Barr most recently was with LXRBiotechnology; L'Eplattenier was responsible for worldwide researchand development at Ciba-Geigy.

* Ligand Pharmaceuticals Inc., of San Diego, said Andres Negro-Vilar will join the company as senior vice president of research andchief scientific officer.

* OXiGENE Inc., of New York, said Bo Haglun joined the companyas chief financial officer. He will be based in Sweden.

* Procept Inc., of Cambridge, Mass., promoted Michal Morse todirector, financial reporting.

* Somatix Therapy Corp., of Alameda, Calif., said Edward LanphierII, executive vice president commercial development, will be actingchief financial officer following the resignation of Mark Bagnall.

* Synsorb Biotech Inc., of Calgary, Alberta, appointed Don Woodsto its scientific advisory board. He is scientific director of theCanadian Bacterial Diseases Network and former chairman of theDepartment of Microbiology at the University of Calgary.

(c) 1997 American Health Consultants. All rights reserved.

No Comments